Evolving Techniques in the Treatment of Liver Colorectal Metastases: Role of Laparoscopy, Radiofrequency Ablation, Microwave Coagulation, Hepatic Arterial Chemotherapy, Indications and Contraindications for Resection, Role of Transplantation, and Timing of Chemotherapy

Surgical Clinics of North America

Volumn 86, Issue 4, 2006, Pages 1005-1022

  Fahy, Bridget N ^a   Jarnagin, William R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN; MITOXANTRONE; OXALIPLATIN; PIRARUBICIN; SEMUSTINE; TEGAFUR; URACIL;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; HEPATIC ARTERY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPY; LIVER METASTASIS; LIVER TRANSPLANTATION; META ANALYSIS; MICROWAVE COAGULATION; MORBIDITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CATHETER ABLATION; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MICROWAVES;

EID: 33746915149     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.06.003     Document Type: Review

References (63)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 1 (2005) 10-30
2. Bengtsson G., Carlsson G., Hafstrom L., et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141 5 (1981) 586-589
3. Taylor I., Mullee M., and Campbell M. Prognostic index for the development of liver metastases in patients with colorectal cancer. Br J Surg 77 5 (1990) 499-501
4. McCarter M., and Fong Y. Metastatic liver tumors. Semin Surg Oncol 19 (2000) 177-188
5. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 6 (2002) 759-766
6. Abdalla E., Vauthey J., Ellis L., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 6 (2004) 818-827
7. Steele G., and Ravikumar T. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210 (1989) 127-138
8. Rahusen F., Cuesta M., Borgstein P., et al. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 230 1 (1999) 31-37
9. Jarnagin W., Conlon K., Bodniewicz J., et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91 6 (2001) 1121-1128
10. Grobmyer S., Fong Y., D'Angelica M., et al. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg 139 (2004) 1326-1330
11. Fong Y., Fortner J., Sun R., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 3 (1999) 309-318
12. Pawlik T., Izzo F., Cohen D., et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10 9 (2003) 1059-1069
13. Bleicher R.J., Allegra D.P., Nora D.T., et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 10 1 (2003) 52-58
14. Seki T., Wakabayashi M., Nakagawa T., et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol 94 (1999) 322-327
15. Shibata T., Niinobu T., Ogata N., et al. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89 (2000) 276-284
16. Kemeny N., and Ron I. Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 26 5 (1999) 524-535
17. Kemeny N.E., and Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med 352 7 (2005) 734-735
18. Kemeny N., Jarnagin W., Gonen M., et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 21 (2003) 3303-3309
19. Fong Y., and Salo J. Surgical therapy of hepatic colorectal metastases. Semin Oncol 26 5 (1999) 514-523
20. Scheele J., Stang R., Altendorf-Hofmann A., et al. Resection of colorectal liver metastases. World J Surg 19 1 (1995) 59-71
21. Jamison R., Donohue J., Nagorney D., et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 132 5 (1997) 505-510
22. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236 4 (2002) 397-406
23. Belghiti J., Hiramatsu K., Benoist S., et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191 1 (2000) 38-46
24. Blumgart L., and Allison D. Resection and embolization in the management of secondary hepatic tumors. World J Surg 6 1 (1982) 32-45
25. Cady B., Monson D., and Swinton N. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131 4 (1970) 697-700
26. Martin R., Paty P., Fong Y., et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197 2 (2003) 233-241 [discussion 241-2]
27. Weber J., Bachellier P., Oussoultzoglou E., et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 90 8 (2003) 956-962
28. Chua H., Sondenaa K., Tsiotos G., et al. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 47 8 (2004) 1310-1316
29. Topal B., Kaufman L., Aerts R., et al. Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol 29 3 (2003) 248-253
30. Bentrem D.J., Dematteo R.P., and Blumgart L.H. Surgical therapy for metastatic disease to the liver. Annu Rev Med 56 (2005) 139-156
31. Petrowsky H., Gonen M., Jarnagin W., et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235 6 (2002) 863-871
32. Detry O., DeRoover A., Delwaide J., et al. Absolute and relative contraindications to liver transplantation. A perpetually moving frontier. Acta Gastroenterol Belg 65 (2002) 133
33. Muhlbacher F., Huk I., Steininger R., et al. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver?. Transplant Proc 23 1 (1991) 1567-1568
34. Honore C., Detry O., DeRoover A., et al. Liver transplantation for metastatic colon adenocarcinoma: report of a case with 10 years of follow-up without recurrence. Transpl Int 16 (2003) 692-693
35. de Gramont A., Bosset J., Milan C., et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 15 2 (1997) 808-815
36. Leonard G., Brenner B., and Kemeny N. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 (2005) 2038-2048
37. Bismuth H., Adam R., Levi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224 4 (1996) 509-520 [discussion 520-2]
38. Adam R., Avisar E., Ariche A., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8 4 (2001) 347-353
39. Allen P.J., Kemeny N., Jarnagin W., et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7 1 (2003) 109-115 [discussion 116-7]
40. Fong Y., Cohen A., and Fortner J. Liver resection for colorectal metastases. J Clin Oncol 15 (1997) 938-946
41. Figueras J., Vallas C., Rafecas A., et al. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 88 7 (2001) 980-985
42. Elias D., Lasser P., Rougier P., et al. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 180 2 (1995) 213-219
43. Link K., Pillasch J., Formentini E., et al. Down staging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Eur J Surg Oncol 25 (1999) 381-388
44. Meric F., Patt Y., Curley S., et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7 7 (2000) 490-495
45. Clavien P., Selzner N., Morse M., et al. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 131 4 (2002) 433-442
46. Milandri C., Calazolari F., and Giampalma E. Combined treatment of inoperable liver metastases from colorectal cancer. Tumori 89 Suppl (2003) 112-114
47. Ducreux M, Ychou M, Laplanche A, et al. Intra-arterial hepatic chemotherapy (IAHC) with oxaliplatin (O) combined with intravenous treatment with 5FU + folinic acid (FA) in hepatic metastases of colorectal cancer. Presented at the 2003 American Society of Clinical Oncology Annual Meeting. Chicago, May 31-June 3, 2003.
48. Noda M, Yanagi H, Yoshikawa R, et al. Second-look hepatectomy after pharmacokinetic modulating chemotherapy (PMC) combination with hepatic arterial 5FU infusion and oral UFT in patients with unresectable hepatic colorectal metastases. Presented at the 2004 American Society of Clinical Oncology Annual Meeting. New Orleans, June 5-8, 2004.
49. Leonard G, Fong Y, Jarnagin W, et al. Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases. Presented at the 2004 American Society of Clinical Oncology Annual Meeting. New Orleans, June 5-8, 2004.
50. Kemeny N., Eid A., Stockman J., et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 91 2 (2005) 97-101
51. Lygidakis N., Ziras N., and Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 42 2 (1995) 155-161
52. Asahara T., Kikkawa M., Okajima M., et al. Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology 45 21 (1998) 805-811
53. Lorenz M., Muller H., Schramm H., et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases. Ann Surg 228 6 (1998) 756-762
54. Rudroff C., Altendorf-Hoffmann A., Stangl R., et al. Prospective randomised trial on adjuvant hepatic artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 384 3 (1999) 243-249
55. Kemeny N., Huang Y., Cohen A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 27 (1999) 2039-2048
56. Tono T., Hasuike Y., Ohzato H., et al. Limited by definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: a randomized study. Cancer 88 7 (2000) 1549-1556
57. Kemeny M.M., Adak S., Gray B., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 20 6 (2002) 1499-1505
58. Kemeny N., Huang Y., Cohen A., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 (1999) 2039-2048
59. Donato N., Dario C., Giovanni S., et al. Retrospective study on adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Eur J Surg Oncol 20 4 (1994) 454-460
60. O'Connell M., Adson M., Schutt A., et al. Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 60 8 (1985) 517-520
61. Butler J., Attiyeh F., and Daly J. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 162 2 (1986) 109-113
62. Iwatsuki S., Esquivel C., Gordon R., et al. Liver resection for metastatic colorectal cancer. Surgery 100 4 (1986) 804-810
63. Kokudo N., Seki M., Ohta H., et al. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol 5 8 (1998) 706-712